This is part of a larger recall. The most authoritative record is FDA-Device / Z-2232-2026.
Medline nerve block kits recalled for bupivacaine quality and efficacy concerns
What this means
Medline distributed medical kits containing bupivacaine injection that were later recalled by the manufacturer due to quality concerns. The injectable anesthetic had microbiology testing data integrity issues and some reports of reduced effectiveness. About 270 kits were affected.
- If you use or manage these kits (SKU DYNJRA1181C or DYNJRA1860), stop use immediately
- Contact Medline for instructions on the affected lot numbers (25DMF105, 25CMB575, or 24DMB099)
- Review your inventory for the specific SKUs and lot numbers listed in the recall notice
The agency's original wording
Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2234-2026More Medline recalls
- FDA-PR2026-08-05Medline Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits recalled for connector overheating risk
- FDA-Device2026-07-29Medline surgical convenience kits recalled for quality issues in anesthetic component
- FDA-Device2026-07-29Medline NEURO PACK medical kits recalled for Bacillus contamination
- FDA-Device2026-07-29Medline convenience kits with Bard Silastic Foley Catheters recalled for surface contamination
- FDA-Device2026-07-29Medline convenience kits with Bard Silastic Foley Catheters recalled for surface contamination
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.